Patent · US Active

Poxviral oncolytic vectors

US9884080B2 · kind B2 · utility

0Cited by
6References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2013
Grant dateFeb 6, 2018
Priority date
Expiry dateFeb 27, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/24143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a poxvirus comprising a defective F4L and/or I4L gene, to composition comprising such poxvirus and to the methods and use of such compositions and poxviruses for therapeutic purposes, and more particularly for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.